Santen (United States)

Recent papers from Santen (United States)

1. The organizational impact of value-based health care: structure-related opportunities and challenges of condition-based units integrated within functional hospital structuresJournal of Health Organization and Management · 2026
2. Abstract 1760: Preclinical characterization of XB404, a masked anti-ROR1/2 antibody-drug conjugateCancer Research · 2026
3. STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24-Month Results of a Randomized, Double-Masked, Vehicle-Controlled Trial of Atropine Sulfate 0.01% and 0.03%Ophthalmology and Therapy · 2026
4. Adverse events among older adults receiving chiropractic spinal manipulation and related treatments: an updated systematic reviewChiropractic & Manual Therapies · 2026
5. Ability of a handheld device to detect need for imaging or hospital admission based on difference in patient applied forceBMJ Innovations · 2026
6. Relaxation of Precontracted Ciliary Artery and Ciliary Muscle In Vitro by Kinin Peptides: Relevance to Retinal Blood Flow and Intraocular Pressure RegulationJournal of Ocular Pharmacology and Therapeutics · 2025
7. Cutamesine (SA4503) Protects Retinal Ganglion Cells in an Ocular Hypertension Model of Glaucoma Determined Using Detection of Apoptosing Retinal Cells Technology and RBPMS Cell MarkerJournal of Ocular Pharmacology and Therapeutics · 2025
8. Posterior Ciliary Artery Contraction by Bradykinin Receptor Subtypes and Implications for Retinal Blood Flow DysfunctionFrontiers in Bioscience-Elite · 2025
9. A Modified Delphi Process to Develop Consensus Definitions of Time-Dependent Care by Paramedic Services SystemsPrehospital and Disaster Medicine · 2025
10. Felodipine re-positioned as a neuroprotectant via improved optic nerve head blood circulation in retinal ischemic rabbits and ocular hypertensive ratsScientific Reports · 2025
11. Pooled Analysis of Three MicroShunt Studies in Primary Open-Angle Glaucoma Evaluating Different Concentrations of Applied Mitomycin COphthalmology and Therapy · 2025
12. The Rate of Failure of Trabeculectomy and Tube Shunt Surgery in Eyes with Uveitic Glaucoma and Ocular HypertensionOphthalmology Glaucoma · 2025
13. Bioequivalence of Preservative-Free and Preserved Omidenepag Isopropyl 0.002% Ophthalmic Solutions in Patients With Primary Open Angle Glaucoma or Ocular Hypertension: Phase 3 DAISY StudyJournal of Glaucoma · 2025
14. Consensus Recommendations for Studies of Outflow Facility and Intraocular Pressure Regulation Using Ex Vivo Perfusion ApproachesInvestigative Ophthalmology & Visual Science · 2024
15. Heparin-Binding Epidermal-like Growth Factor (HB-EGF) Reduces Cell Death in an Organoid Model of Retinal DamageOrganoids · 2024
16. Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY TrialClinical ophthalmology · 2024
17. Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve CrushPharmaceuticals · 2024
18. Giant retinal pigment epithelial tear following photodynamic therapy for the bullous variant of central serous chorioretinopathy: A case reportMedicine · 2024
19. Steroid-Induced Ocular Hypertension in Mice Is Differentially Reduced by Selective EP2, EP3, EP4, and IP Prostanoid Receptor AgonistsInternational Journal of Molecular Sciences · 2024
20. Nonsurgical closure of full thickness macular hole under topical therapy in two eyes with pathologic myopiaRetinal Cases & Brief Reports · 2024